Dynamics of Histoplasma fungal load in people living with HIV with disseminated histoplasmosis under treatment with liposomal amphotericin B.

IF 10.9 1区 医学 Q1 INFECTIOUS DISEASES
Aude Sturny-Leclère, Elodie Da Silva, Cassia S M Godoy, Renata B A Soares, Terezinha do Menino Jesus Silva Leitão, Lisandra Serra Damasceno, Monica B Bay, Marineide Melo, Daiane Dalla Lana, Larissa R Silva, Dennis Israelski, Diego R Falci, Alessandro C Pasqualotto, Alexandre Alanio
{"title":"Dynamics of Histoplasma fungal load in people living with HIV with disseminated histoplasmosis under treatment with liposomal amphotericin B.","authors":"Aude Sturny-Leclère, Elodie Da Silva, Cassia S M Godoy, Renata B A Soares, Terezinha do Menino Jesus Silva Leitão, Lisandra Serra Damasceno, Monica B Bay, Marineide Melo, Daiane Dalla Lana, Larissa R Silva, Dennis Israelski, Diego R Falci, Alessandro C Pasqualotto, Alexandre Alanio","doi":"10.1016/j.cmi.2024.11.037","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>Disseminated histoplasmosis (DH) is a lethal fungal disease in patients living with HIV in endemic regions of the world. Diagnosis relies mainly on microscopy, culture, and antigen detection. Our goal was to evaluate the diagnostic and prognostic role of our RT-quantitative PCR (RT-qPCR) in blood specimens allowing to quantify the whole nucleic acids (WNA) load.</p><p><strong>Methods: </strong>We tested RT-qPCR assays on serial blood (n = 325) of 105 DH patients at baseline (day 0 or day 1, D0/1) and during antifungal therapy (day 3, D3; day 4 or day 5, D4/5; day 7, D7; and day 14, D14) collected from a phase II trial comparing three different regimens of liposomal amphotericin B for DH treatment in HIV patients from Brazil.</p><p><strong>Results: </strong>The RT-qPCR was positive at D0/D1 in 64.2% (63/98) of the patients, but positivity increased to 89% (47/53) in patients with proven infection. Urine antigen was positive in 94.2% (97/103) of DH patients. RT-qPCR positive at or after D7 was significantly associated with higher initial WNA load (Cq = 31 [27-34]) when compared with RT-qPCR negative at D7 (Cq = 38 [33-40]) (p 0.001). The WNA load was equivalent in all treatment arms, and an equivalent decrease in the % of RT-qPCR-positive patients was observed in the three arms. Flat of negative WNA slope (increase of WNA load) was associated with an increased relative risk of death at D7 (relative risk, 8.6; p 0.046) and W12 (relative risk, 3.3; p 0.008). This association was not observed when analysing antigen slopes (p > 0.5).</p><p><strong>Discussion: </strong>We found in this study an association between the progression of flat Histoplasma WNA load during treatment and early death at D7 and D14. This diagnostic tool should be evaluated specifically in a prospective trial to assess its usefulness in identifying patients with poorer prognosis and adapt their treatment accordingly.</p>","PeriodicalId":10444,"journal":{"name":"Clinical Microbiology and Infection","volume":" ","pages":""},"PeriodicalIF":10.9000,"publicationDate":"2024-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Microbiology and Infection","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.cmi.2024.11.037","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: Disseminated histoplasmosis (DH) is a lethal fungal disease in patients living with HIV in endemic regions of the world. Diagnosis relies mainly on microscopy, culture, and antigen detection. Our goal was to evaluate the diagnostic and prognostic role of our RT-quantitative PCR (RT-qPCR) in blood specimens allowing to quantify the whole nucleic acids (WNA) load.

Methods: We tested RT-qPCR assays on serial blood (n = 325) of 105 DH patients at baseline (day 0 or day 1, D0/1) and during antifungal therapy (day 3, D3; day 4 or day 5, D4/5; day 7, D7; and day 14, D14) collected from a phase II trial comparing three different regimens of liposomal amphotericin B for DH treatment in HIV patients from Brazil.

Results: The RT-qPCR was positive at D0/D1 in 64.2% (63/98) of the patients, but positivity increased to 89% (47/53) in patients with proven infection. Urine antigen was positive in 94.2% (97/103) of DH patients. RT-qPCR positive at or after D7 was significantly associated with higher initial WNA load (Cq = 31 [27-34]) when compared with RT-qPCR negative at D7 (Cq = 38 [33-40]) (p 0.001). The WNA load was equivalent in all treatment arms, and an equivalent decrease in the % of RT-qPCR-positive patients was observed in the three arms. Flat of negative WNA slope (increase of WNA load) was associated with an increased relative risk of death at D7 (relative risk, 8.6; p 0.046) and W12 (relative risk, 3.3; p 0.008). This association was not observed when analysing antigen slopes (p > 0.5).

Discussion: We found in this study an association between the progression of flat Histoplasma WNA load during treatment and early death at D7 and D14. This diagnostic tool should be evaluated specifically in a prospective trial to assess its usefulness in identifying patients with poorer prognosis and adapt their treatment accordingly.

两性霉素B脂质体治疗下HIV弥散性组织浆菌病患者的组织浆菌负荷动态变化
目的:播散性组织胞浆菌病(DH)是世界流行地区HIV患者的一种致命真菌疾病。诊断主要依靠显微镜、培养和抗原检测。我们的目标是评估我们的逆转录酶定量PCR (RTqPCR)在血液标本中的诊断和预后作用,从而量化全核酸(WNA)负荷。方法:我们对105例DH患者在基线(第0天或第1天,D0/1)和抗真菌治疗期间(第3天,D3;第4或第5天,D4/5;第7天,D7;(第14天,D14),收集自一项II期试验,比较了三种不同的脂质体两性霉素B治疗巴西HIV患者DH的方案。结果:64.2%(63/98)的患者RTqPCR为D0/D1阳性,而确诊感染的患者RTqPCR为89%(47/53)。94.2% (97/103) DH患者尿抗原阳性。与D7时RTqPCR阴性(Cq=38[33-40])相比,D7时或之后RTqPCR阳性与更高的初始WNA负荷显著相关(Cq=31 [27-34]) (p=0.001)。WNA负荷在所有治疗组中都是相同的,并且在三个治疗组中观察到rtqpcr阳性患者百分比的相同下降。在D7 (RR=8.6, p=0.046)和W12 (RR=3.3, p=0.008)时,负WNA斜率平坦(WNA负荷增加)与相对死亡风险增加相关。在分析抗原斜率时没有观察到这种关联(p>0.5)。结论:我们在本研究中发现,治疗期间扁平组织浆体WNA载量的进展与D7和D14的早期死亡之间存在关联。这种诊断工具应该在前瞻性试验中进行专门评估,以评估其在识别预后较差的患者并相应地调整其治疗方面的有用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
25.30
自引率
2.10%
发文量
441
审稿时长
2-4 weeks
期刊介绍: Clinical Microbiology and Infection (CMI) is a monthly journal published by the European Society of Clinical Microbiology and Infectious Diseases. It focuses on peer-reviewed papers covering basic and applied research in microbiology, infectious diseases, virology, parasitology, immunology, and epidemiology as they relate to therapy and diagnostics.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信